Public Policy Archives - Page 3 of 8 - National Venture Capital Association

Category: Public Policy

VC Policy Pulse: Medical Device Coverage Reform with Vensana’s Justin Klein & Kirk Nielsen

blog, Healthcare Innovation, Public Policy March 30, 2021/by Devin Miller

Welcome to our VC Policy Pulse series, where we speak with VC investors on policy issues that are having a major impact on the VC and startup ecosystem. Today, we’re hearing from Justin Klein and Kirk Nielsen, co-founders & Managing Partners of Vensana Capital, about the effects of federal policy on medical device innovation in the U.S. and how reformed coverage policy for innovative technologies from the Centers for Medicare & Medicaid Services (CMS) could help advance new medical devices and accelerate access to these products for Americans. Read more

Creating the Next Moderna: What VC Offers the World and 3 Public Policy Lessons

blog, Public Policy November 30, 2020/by Jeff Farrah

The world has anxiously waited for encouraging news about COVID-19 vaccine candidates. Happily, this news came right before Thanksgiving, with Moderna reporting that its vaccine is more than 94% effective and Pfizer indicating that its vaccine was similarly effective. Read more

Venture Capital Fuels America’s Recovery: Infographic

blog, Public Policy November 4, 2020/by Devin Miller

At NVCA, we understand that venture capital powers the American economy, and we advocate that venture is a key component to keeping our economy strong through the COVID-19 pandemic fallout.

American startups are the most innovative companies in the world, and many that are backed by VC are currently using their resources and human capital to combat COVID-19. Large companies often dominate the headlines, but nimble high-growth companies are the ones re-defining the boundaries of science and technology. Some of these companies were previously in the healthcare space and have shifted their attention solely to addressing COVID-19, while others were previously in other sectors and have pivoted to do their part. Read more

VC Policy Pulse: the Volcker Rule with Mark Kvamme

blog, Capital Formation & Regulation, Public Policy September 29, 2020/by Devin Miller

Welcome to the first blog in our VC Policy Pulse series, where we speak with a VC investor on a policy issue that is having a major impact on the VC and startup ecosystem. Today, we’re hearing from Mark Kvamme, Co-Founder & Partner at Drive Capital and former NVCA Board Member, about the effects of the Volcker Rule on the startup ecosystem in the Midwest and how recent reform to the rule will increase VC investment and startup activity in the middle of the country. Read more

8 VC-Backed Startups Helping Treat COVID-19

blog, Public Policy June 25, 2020/by Devin Miller

As the COVID-19 pandemic continues to impact the world, many U.S. VC-backed startups are helping fight the virus by developing, testing, and implementing treatments that can manage, alleviate, or even prevent the symptoms of COVID-19. The venture industry is proud to support these innovative companies by providing capital and strategic guidance that is essential to tackling the crisis. Read more

How 10 VC-Backed Startups are Combating COVID-19

blog, Public Policy May 28, 2020/by Devin Miller

Many of America’s startups are currently researching and producing advanced technologies needed to fight COVID-19. Nimble, high-growth companies have frequently re-defined the boundaries of science and technology, and many startups are using their capabilities and expertise to find and develop the technology-driven solutions needed to get past this pandemic. Read more

How Startups and Entrepreneurs Can Power the Economic Recovery

blog, Public Policy, Venture Investment May 13, 2020/by Ross DeVol

We worked with Ross DeVol, President and CEO of Heartland Forward, on this partner blog post to highlight the importance of entrepreneurs and startups during this crisis and how they could be the engine to get people back to work.

It should come as no surprise to the NVCA community that entrepreneurs are critical to the economy’s long-term success. Heartland Forward, a think-and-do tank based in Bentonville, Arkansas, put cold, hard numbers behind this claim with our latest research report, “Young Firms and Regional Economic Growth.” As local economies begin to rebuild post-COVID-19, these entrepreneurs and their young firms (defined as businesses five years old or less) could be the engine to get people back to work. The venture capital community can continue to play an important role in helping strengthen our country’s entrepreneurial ecosystem. Read more

Startup Ecosystem Faces Capital Crunch over Coming Months – What We Expect & Why It Matters

blog, Public Policy, Research April 28, 2020/by Maryam Haque

The U.S. startup ecosystem has rapidly entered a new chapter of what will be a turbulent period over at least the next several quarters. Investment in the startup ecosystem is expected to drop significantly at a time when the country needs it most for company and job creation towards economic recovery from the global pandemic. NVCA released a white paper outlining what we believe the industry may look like over the coming months as this crisis evolves. Read more

CFIUS & VC: 3 Takeaways from the Final Rules and What Investors Must Know

blog, Foreign Investment, Public Policy January 27, 2020/1 Comment/by Jeff Farrah

The Treasury Department recently released the long awaited final rules implementing the Foreign Investment Risk Review Modernization Act (FIRRMA), and they go into effect February 13, 2020. Through FIRRMA, Congress gave CFIUS significant new powers to police investments into certain U.S. companies and has made CFIUS highly relevant in the startup ecosystem. CFIUS’s power was demonstrated in recent high-profile cases that forced Chinese investors to divest of holdings in Grindr, PatientsLikeMe, and Musical.ly. The combination of CFIUS interest in data rich companies and their expanded authority over non-controlling investments means the agency will be a player in the startup ecosystem going forward. Read more

NIH is the World’s Largest Early Stage Life Sciences Investor That You Didn’t Know About

blog, Life Science, Public Policy July 11, 2019/by

What can NIH offer to NVCA member firm’s life science portfolio companies? How can you get access to NIH funded companies? Since when does NIH have Entrepreneurs in Residence? Check out the answers to these questions and more in our first Q&A session with NIH investment executives, Dr. Ethel Rubin and John Sullivan. To cultivate the relationship between NIH and NVCA members, Ethel and John will be publishing a variety of Q&A sessions on topics such as NIH non-dilutive funding, resources open to investors, recent VC deals from their portfolio, and more. Read more

Member Spotlight: Callais Capital

blog, Member Spotlight November 30, 2022/by Savanna Maloney

For this deep dive, we spoke to Harold Callais, Managing Partner + CIO of Callais Capital.

Listen & Learn from Veteran VC CFOs/COOs

blog November 15, 2022/by Jason Vita and Robin Ceppos

NVCA successfully hosted its sixth annual Strategic Operations and Policy Summit in Washington, D.C., earlier this month. The 1.5-day conference, developed in collaboration with NVCA’s CFO Taskforce, attracted 110+ senior operators from North American venture firms. The big picture: According to Jim Stewart, CFO of True Ventures, the event is “unparalleled in terms of its […]